Transplantation, AutologousPeripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationStem Cell TransplantationTransplantation ConditioningTransplantation, HomologousHematopoietic Stem Cell MobilizationMelphalanCombined Modality TherapyMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsHematologic NeoplasmsGranulocyte Colony-Stimulating FactorLeukapheresisAntigens, CD34CyclophosphamideTreatment OutcomeMyeloablative AgonistsBlood Component RemovalGraft vs Host DiseaseLymphoma, Non-HodgkinRemission InductionEtoposideBusulfanBone Marrow TransplantationThiotepaGraft SurvivalRecurrenceSalvage TherapyHematopoietic Stem CellsStem CellsCarmustineAntineoplastic Agents, AlkylatingDisease-Free SurvivalHodgkin DiseaseCytarabineVincristineAmyloidosisIfosfamideSurvival RateRetrospective StudiesSurvival AnalysisWhole-Body IrradiationCord Blood Stem Cell TransplantationDoxorubicinTransplantation ChimeraCytophagocytosisHematopoiesisTissue DonorsBone Marrow PurgingTime FactorsDexamethasoneNeoplasmsPrednisoneFollow-Up StudiesAntineoplastic AgentsLeukemia, Myeloid, AcuteHistocompatibilityCarboplatinLymphomaHistocompatibility TestingImmunosuppressive AgentsInfectionPrognosisLiver TransplantationPlatelet CountVidarabineLymphoma, T-CellProspective StudiesLeukemiaTransplantation, IsogeneicFatal OutcomeFeasibility StudiesMyelodysplastic SyndromesPOEMS SyndromeMesenchymal Stem Cell TransplantationGraft vs Leukemia EffectRecombinant ProteinsCytomegalovirus InfectionsBlood Cell CountNeoplasm, ResidualCell TransplantationLymphoma, Mantle-CellAntibodies, Monoclonal, Murine-DerivedBlood CellsBlood Transfusion, AutologousKidney TransplantationBone MarrowT-LymphocytesEmbryonic Stem CellsAnemia, AplasticPrecursor Cell Lymphoblastic Leukemia-LymphomaPodophyllotoxinImmunophenotypingBoronic AcidsHematologic DiseasesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBreast NeoplasmsLymphocyte DepletionPyrazines